Revision of USP Chapter <541> Titrimetry
Recommendation

3/4 February 2026
Evaluation, Implementation and Use of Suitable Technologies
In the Pharmacopeial Forum, PF 48(5), a revision of USP chapter <541> Titrimetry is being proposed. The proposal is based on the version of the chapter official prior to 2013.
The chapter was previously divided into the following main sections:
- Direct titrations
- Residual titrations
- Complexometric titrations
- Oxidation-reduction (Redox) titrations
- Titrations in nonaqueros solvents
- Indicator and potentiometric endpoint detection
- Blank corrections
- Introduction
- Types of titrations
- Materials and equipment
In addition, besides minor editorial changes, the following updates are mentioned in the briefing notes:
- "Incorporate most of the currently official chapter information into the revised chapter in corresponding sections with the same section titles, if applicable.
- Replace Table 1 and Table 2 with information provided under Types of Titrations and Materials and Equipment.
- Add Automated Titration and Standardization of Titrants to provide current information regarding modern titrimetry processes."
The draft of the revised chapter is available on PF Online. Comments can be submitted until November 30, 2022.
Related GMP News
18.12.2025FDA Form 483: Excel-Based Data Falsification and Duplicate Log Books
18.12.2025Questions and Answers on System Suitability Tests (SST) - Part 1
18.12.2025PharmaLab 2025: Brief Summary of AQCG Track - Save the Date for 2026!
18.12.2025FDA Warning Letter: 1,500 OOS Results with Numerous Inadequate Investigations
17.12.2025FDA Warning Letter Criticises Handling of OOS Results at a Contract Laboratory
17.12.2025FDA Warning: No Recall Conducted Despite Confirmed Benzene Impurity


